Drug Guide
Methylprednisolone
Classification
Therapeutic: Anti-inflammatory, Immunosuppressant
Pharmacological: Glucocorticoid
FDA Approved Indications
- Inflammatory and autoimmune disorders
- Allergic reactions
- Asthma exacerbations
- Multiple sclerosis flare-ups
- Adrenal insufficiency
Mechanism of Action
Methylprednisolone binds to glucocorticoid receptors, resulting in modulation of gene expression that suppresses inflammation and immune responses.
Dosage and Administration
Adult: Dose varies based on condition; commonly 4-48 mg daily, divided doses; adjust based on response and severity.
Pediatric: Dosing is weight-based; usually 0.05-2 mg/kg/day in divided doses.
Geriatric: Use with caution; start at lower end of dosing range due to increased risk of side effects.
Renal Impairment: Adjust dose based on severity of impairment, closely monitor response.
Hepatic Impairment: No specific adjustment recommended, but monitor for enhanced effects or toxicity.
Pharmacokinetics
Absorption: Rapidly absorbed after oral administration.
Distribution: Widely distributed, crosses the placenta, and enters breast milk.
Metabolism: Metabolized hepatically via CYP3A4.
Excretion: Primarily excreted in urine as metabolites.
Half Life: Approximately 18-36 hours.
Contraindications
- Systemic fungal infections
- Hypersensitivity to methylprednisolone or other corticosteroids
Precautions
- Use with caution in active infections, osteoporosis, ulcers, diabetes, hypertension, psychiatric disorders, and during pregnancy/lactation. Monitor for side effects.
Adverse Reactions - Common
- Increased appetite, weight gain (Common)
- Insomnia, nervousness (Common)
- Mood changes, fluid retention (Common)
Adverse Reactions - Serious
- Adrenal suppression (Rare)
- Osteoporosis with long-term use (Rare)
- Hyperglycemia, hypertension (Less common)
- Increased risk of infection (Less common)
Drug-Drug Interactions
- NSAIDs (increased gastrointestinal risk)
- Vaccines (live vaccines may be ineffective)
- Diuretics (potassium loss)
- Antidiabetic agents (altered glucose control)
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Monitor blood pressure, electrolytes, blood glucose, signs of infection, and bone density during long-term therapy.
Diagnoses:
- Impaired tissue perfusion related to corticosteroid effects
- Risk of infection due to immunosuppression
- Potential for fluid volume overload
Implementation: Administer with food to reduce GI irritation; taper dose gradually to prevent adrenal insufficiency.
Evaluation: Assess effectiveness in controlling inflammatory symptoms; monitor side effects.
Patient/Family Teaching
- Take medication exactly as prescribed.
- Do not stop abruptly; taper off under medical supervision.
- Report signs of infection, hyperglycemia, or mood changes.
- Use caution when performing activities that require alertness.
- Maintain regular follow-up appointments.
Special Considerations
Black Box Warnings:
- Increased risk of infection and masking symptoms of infection; risk of osteoporosis with long-term use.
Genetic Factors: None specific.
Lab Test Interference: May induce false elevation of blood glucose and eosinophil count.
Overdose Management
Signs/Symptoms: Fluid retention, hyperglycemia, hypertension, hypokalemia.
Treatment: Discontinue corticosteroid gradually; symptomatic and supportive care; manage electrolyte imbalance and blood pressure.
Storage and Handling
Storage: Store at room temperature away from light and moisture.
Stability: Stable for 2-3 years when stored properly.